What are the Advantages Over Other Sources of L-Asparaginase?
Compared to other sources like E. coli-derived L-asparaginase, Erwinia chrysanthemi L-asparaginase has certain benefits. It tends to be less immunogenic, meaning it is less likely to trigger adverse immune responses in patients undergoing treatment. This makes it a preferable choice for patients who develop hypersensitivity to E. coli-derived enzymes. The enzyme's unique catalytic properties and lower immunogenicity enhance its therapeutic value.
